Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

Here is your 2025 hard rock + metal album release calendar and all of this week's newest albums! Each week is loaded with new rock and metal releases and keeping track of it all can be pretty ...